{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T19:52:53Z","timestamp":1781034773783,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1067\/moe.2001.116600","type":"journal-article","created":{"date-parts":[[2002,8,24]],"date-time":"2002-08-24T18:14:26Z","timestamp":1030212866000},"page":"170-179","source":"Crossref","is-referenced-by-count":58,"title":["A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients"],"prefix":"10.1067","volume":"92","author":[{"given":"Lauren L.","family":"Patton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur J.","family":"Bonito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Shugars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/moe.2001.116600_bib1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0030-4220(94)90149-X","article-title":"Treatment of oral candidiasis in HIV infection","volume":"78","author":"Greenspan","year":"1994","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1067\/moe.2001.116600_bib2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/00042560-199608150-00005","article-title":"Prophylaxis with nystatin pastilles for HIV-associated oral candidiasis","volume":"12","author":"MacPhail","year":"1996","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1067\/moe.2001.116600_bib3","first-page":"1","article-title":"1999 USPHS\/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1067\/moe.2001.116600_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0002-9343(98)00137-5","article-title":"A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance","volume":"105","author":"Revankar","year":"1998","journal-title":"Am J Med"},{"key":"10.1067\/moe.2001.116600_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/bmj.2.6181.14","article-title":"Relation between medicines sweetened with sucrose and dental disease","volume":"2","author":"Roberts","year":"1979","journal-title":"Br Med J"},{"key":"10.1067\/moe.2001.116600_bib6","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1001\/archinte.1991.00400120096018","article-title":"Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily","volume":"151","author":"Stevens","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1067\/moe.2001.116600_bib7","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-126-9-199705010-00003","article-title":"Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS","volume":"126","author":"Schuman","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1067\/moe.2001.116600_bib8","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1079-2104(98)90291-8","article-title":"Fluconazole-resistant Candida species in the oral flora of fluconazole-exposed HIV-positive patients","volume":"85","author":"Hunter","year":"1998","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"Suppl 1","key":"10.1067\/moe.2001.116600_bib9","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1111\/j.1601-0825.1997.tb00337.x","article-title":"Fluconazole resistant oral candidiasis in HIV-infected patients","volume":"3","author":"Tumbarello","year":"1997","journal-title":"Oral Dis"},{"key":"10.1067\/moe.2001.116600_bib10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0002-9343(94)90300-X","article-title":"Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance","volume":"97","author":"Sangeorzan","year":"1994","journal-title":"Am J Med"},{"key":"10.1067\/moe.2001.116600_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/infdis\/173.1.219","article-title":"Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients","volume":"173","author":"Maenza","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1067\/moe.2001.116600_bib12","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/clinids\/17.6.1018","article-title":"Fluconazole-resistant Candida albicans","volume":"17","author":"Boken","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1067\/moe.2001.116600_bib13","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1089\/088922299309919","article-title":"Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients","volume":"15","author":"Saag","year":"1999","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1067\/moe.2001.116600_bib14","first-page":"470","article-title":"Assessing \u2018best evidence\u2019: issues in grading the quality of studies for systematic reviews","volume":"25","author":"Lohr","year":"1999","journal-title":"Joint Comm J Qual Improv"},{"key":"10.1067\/moe.2001.116600_bib15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of reporting of randomized controlled trials. The CONSORT statement","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"key":"10.1067\/moe.2001.116600_bib16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5694\/j.1326-5377.1993.tb121784.x","article-title":"Fluconazole once a week as secondary prophylaxis against oropharyngeal candidiasis in HIV-infected patients. A double-blind placebo-controlled study","volume":"158","author":"Marriott","year":"1993","journal-title":"Med J Aust"},{"key":"10.1067\/moe.2001.116600_bib17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0163-4453(90)90646-P","article-title":"Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study","volume":"21","author":"Leen","year":"1990","journal-title":"J Infect"},{"key":"10.1067\/moe.2001.116600_bib18","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/BF02005444","article-title":"Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients","volume":"10","author":"Just-Nubling","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1067\/moe.2001.116600_bib19","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1086\/516342","article-title":"A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS","volume":"26","author":"Phillips","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1067\/moe.2001.116600_bib20","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(89)92572-5","article-title":"Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS","volume":"1","author":"De Wit","year":"1989","journal-title":"Lancet"},{"key":"10.1067\/moe.2001.116600_bib21","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000239469","article-title":"Comparison of itraconazole and ketoconazole in HIV-positive patients with oropharyngeal or esophageal candidiasis. Human Immunodeficiency Virus Itraconazole Ketoconazole Project Group","volume":"42","author":"De Repentigny","year":"1996","journal-title":"Chemotherapy"},{"key":"10.1067\/moe.2001.116600_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0002-9343(97)00307-0","article-title":"Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV\/AIDS patients","volume":"104","author":"Graybill","year":"1998","journal-title":"Am J Med"},{"key":"10.1067\/moe.2001.116600_bib23","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1086\/513664","article-title":"Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions","volume":"24","author":"Pons","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1067\/moe.2001.116600_bib24","first-page":"1311","article-title":"Therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches","volume":"6","author":"Pons","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1067\/moe.2001.116600_bib25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0149-2918(97)80131-2","article-title":"Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients","volume":"19","author":"Murray","year":"1997","journal-title":"Clin Ther"},{"key":"10.1067\/moe.2001.116600_bib26","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0022-3476(95)70321-7","article-title":"Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspension versus nystatin","volume":"127","author":"Flynn","year":"1995","journal-title":"J Pediatr"},{"key":"10.1067\/moe.2001.116600_bib27","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1128\/AAC.34.11.2267","article-title":"Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus","volume":"34","author":"Koletar","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1067\/moe.2001.116600_bib28","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF01974616","article-title":"Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children","volume":"13","author":"Hernandez-Sampelayo","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1067\/moe.2001.116600_bib29","first-page":"45","article-title":"Gentian violet, ketoconazole and nystatin in oropharyngeal and esophageal candidiasis in Zairian AIDS patients","volume":"72","author":"Nyst","year":"1992","journal-title":"Ann Soc Belg Med Trop"},{"key":"10.1067\/moe.2001.116600_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/030006059802600307","article-title":"Safety and efficacy of single-dose fluconazole compared with a 7-day regimen of itraconazole in the treatment of AIDS-related oropharyngeal candidiasis","volume":"26","author":"De Wit","year":"1998","journal-title":"J Int Med Res"},{"key":"10.1067\/moe.2001.116600_bib31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00126334-199905010-00003","article-title":"Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study","volume":"21","author":"Cauda","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1067\/moe.2001.116600_bib32","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/314871","article-title":"In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors","volume":"180","author":"Cassone","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1067\/moe.2001.116600_bib33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1001\/jama.279.2.130","article-title":"The cost-effectiveness of preventing AIDS-related opportunistic infections","volume":"279","author":"Freedberg","year":"1998","journal-title":"JAMA"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210401868013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210401868013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,15]],"date-time":"2019-12-15T21:19:23Z","timestamp":1576444763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079210401868013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["S1079210401868013"],"URL":"https:\/\/doi.org\/10.1067\/moe.2001.116600","relation":{},"ISSN":["1079-2104"],"issn-type":[{"value":"1079-2104","type":"print"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}